Search results for "Cardiovascular events"
Calculating risk for cholesterol drugs
Differing guidelines and a new class of drugs may cause uncertainty on the part of patients and practitioners.
https://immattersacp.org/archives/2015/11/cholesterol.htm
1 Nov 2015
MKSAP Quiz: Evaluation of risk for cardiovascular disease
A 49-year-old man is evaluated during a routine examination. He is asymptomatic but is concerned about his risk for cardiovascular disease. Medical history is notable for hypertension. He is a nonsmoker, and he works as an executive at a highly successful company. Family history is noncontributory. His only medication is hydrochlorothiazide. Following a physical exam and cholesterol and glucose testing, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2016/02/09/3.htm
9 Feb 2016
Combat cardiac risks of cancer therapies
One challenge of treating cancer is preventing, diagnosing, and treating heart failure in at-risk patients, and figuring out which patients would benefit from intervention.
https://immattersacp.org/archives/2018/09/combat-cardiac-risks-of-cancer-therapies.htm
1 Sep 2018
ADHD drugs appear to present no cardiovascular risks in adults
Attention-deficit/hyperactivity disorder medications were not associated with an increased risk of serious cardiovascular events among young and middle-aged adults, researchers found.
https://immattersacp.org/weekly/archives/2011/12/20/2.htm
20 Dec 2011
Hormone therapy stirs debate 10 years after WHI
The Women's Health Initiative dramatically decreased hormone therapy for menopause, but 10 years later, the “knee-jerk” reaction has become more nuanced in how the regimen can be used.
https://immattersacp.org/archives/2012/09/hormones.htm
1 Sep 2012
Beta-blockers didn't benefit stable CAD patients
Taking beta-blockers did not reduce the risk of cardiovascular events for patients with no history or a remote history of myocardial infarction (MI), according to a recent study.
https://immattersacp.org/weekly/archives/2012/10/16/6.htm
16 Oct 2012
Chlorthalidone associated with electrolyte abnormalities in older hypertensive patients
Chlorthalidone does not lead to fewer cardiovascular events and deaths than hydrochlorothiazide but may be more likely to cause electrolyte imbalances, especially hypokalemia, according to a new study.
https://immattersacp.org/weekly/archives/2013/03/19/2.htm
19 Mar 2013
Angina not associated with mortality in diabetes patients with coronary artery disease
Patients with type 2 diabetes and stable coronary artery disease had similar risk of cardiovascular events and death, regardless of whether they had angina or angina-like symptoms, a study found.
https://immattersacp.org/weekly/archives/2013/02/12/2.htm
12 Feb 2013
Rosiglitazone restricted to patients who can't take other drugs
Preprocedural statins reduce risk of postprocedure cardiovascular events
https://immattersacp.org/weekly/archives/2010/09/28/4.htm
28 Sep 2010
Telmisartan and valsartan associated with fewer hospital admissions than other ARBs, study finds
In patients with diabetes, telmisartan and valsartan were associated with lower rates of hospitalization for cardiovascular events than other angiotensin-receptor blockers (ARBs), according to a recent retrospective study.
https://immattersacp.org/weekly/archives/2013/07/16/4.htm
16 Jul 2013